Figure 4.

Percent change in congestion symptom score in a pooled analysis of 4 studies with mometasone furoate in seasonal allergic rhinitis. The magnitude of change was greatest in patients with the highest baseline congestion scores. Mean baseline congestion scores in the overall population were 2.24 in the mometasone furoate group and 2.25 in the placebo group. In the >2.5 baseline congestion score group, the baseline scores were 2.83 (mometasone furoate) and 2.84 (placebo). In the >2.75 group, the baseline scores were 2.94 in both the mometasone furoate and placebo groups. ^aP < 0.001 vs placebo. Adapted with permission from Berger WE, Nayak AS, Staudinger HW. Mometasone furoate improves congestion in patients with moderate-to-severe seasonal allergic rhinitis. Ann Pharmacother. 2005;39(12):1984–1989.¹⁰⁰ Copyright © 2005 Harvey Whitney Books Co.